{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T21:48:46Z","timestamp":1780609726999,"version":"3.54.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Bayer Healthcare Company Ltd., Beijing China"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12325-025-03384-4","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T07:50:56Z","timestamp":1760341856000},"page":"6118-6131","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Medical Cost and Healthcare Utilization in Adults with Chronic Kidney Disease and Type\u00a02 Diabetes in a Chinese Regional Population"],"prefix":"10.1007","volume":"42","author":[{"given":"Zaixin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yexiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"3384_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"P Saeedi","year":"2019","unstructured":"Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. 2019;157:107843.","journal-title":"Diabetes Res Clin Pract"},{"key":"3384_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","volume":"128","author":"K Ogurtsova","year":"2017","unstructured":"Ogurtsova K, da Rocha Fernandes JD, Huang Y, et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40\u201350.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"3384_CR3","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.07.011103","volume":"7","author":"H Wu","year":"2017","unstructured":"Wu H, Meng X, Wild SH, Gasevic D, Jackson CA. Socioeconomic status and prevalence of type\u00a02 diabetes in mainland China, Hong Kong and Taiwan: a systematic review. J Glob Health. 2017;7(1):011103.","journal-title":"J Glob Health"},{"issue":"1","key":"3384_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s13300-015-0096-0","volume":"6","author":"H Hu","year":"2015","unstructured":"Hu H, Sawhney M, Shi L, et al. A systematic review of the direct economic burden of type\u00a02 diabetes in China. Diabetes Ther. 2015;6(1):7\u201316.","journal-title":"Diabetes Ther"},{"issue":"3","key":"3384_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/MNH.0000000000000213","volume":"25","author":"M Sud","year":"2016","unstructured":"Sud M, Naimark DM. Cardiovascular disease in chronic kidney disease in 2015. Curr Opin Nephrol Hypertens. 2016;25(3):203\u20137.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"6","key":"3384_CR6","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1001\/jama.2016.10924","volume":"316","author":"M Afkarian","year":"2016","unstructured":"Afkarian M, Zelnick LR, Hall YN, et al. Clinical manifestations of kidney disease among US adults with diabetes, 1988\u20132014. JAMA. 2016;316(6):602\u201310.","journal-title":"JAMA"},{"issue":"11","key":"3384_CR7","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1016\/j.clinthera.2009.10.020","volume":"31","author":"CE Koro","year":"2009","unstructured":"Koro CE, Lee BH, Bowlin SJ. Antidiabetic medication use and prevalence of chronic kidney disease among patients with type\u00a02 diabetes mellitus in the United States. Clin Ther. 2009;31(11):2608\u201317.","journal-title":"Clin Ther"},{"issue":"1","key":"3384_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2015-000154","volume":"4","author":"B Wu","year":"2016","unstructured":"Wu B, Bell K, Stanford A, et al. Understanding CKD among patients with T2DM: prevalence, temporal trends, and treatment patterns\u2014NHANES 2007\u20132012. BMJ Open Diabetes Res Care. 2016;4(1):e000154.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"1","key":"3384_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jdiacomp.2013.09.014","volume":"28","author":"S Vupputuri","year":"2014","unstructured":"Vupputuri S, Kimes TM, Calloway MO, et al. The economic burden of progressive chronic kidney disease among patients with type\u00a02 diabetes. J Diabetes Complications. 2014;28(1):10\u20136.","journal-title":"J Diabetes Complications"},{"issue":"12","key":"3384_CR10","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/CJN.11491116","volume":"12","author":"RZ Alicic","year":"2017","unstructured":"Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12(12):2032\u201345.","journal-title":"Clin J Am Soc Nephrol"},{"key":"3384_CR11","doi-asserted-by":"crossref","unstructured":"GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709\u201333.","DOI":"10.1016\/S0140-6736(19)32977-0"},{"issue":"7","key":"3384_CR12","volume":"18","author":"Q Liu","year":"2015","unstructured":"Liu Q, Liu M, Zhang J, Chu Y, Li Z, Wang D. PDB47\u2014Direct cost and medication usage among insured type\u00a02 diabetes patients with chronic kidney disease under hospitalization in Beijing and Tianjin, China. Value Health. 2015;18(7):A605.","journal-title":"Value Health"},{"issue":"2","key":"3384_CR13","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1016\/j.kisu.2020.09.001","volume":"10","author":"L Zhang","year":"2020","unstructured":"Zhang L, Zhao M-H, Zuo L, et al. China kidney disease network (CK-NET) 2016 annual data report. Kidney Int Suppl. 2020;10(2):e97\u2013185.","journal-title":"Kidney Int Suppl"},{"issue":"9","key":"3384_CR14","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"key":"3384_CR15","unstructured":"National Bureau of Statistics of China. Consumer price index (CPI) - Medical care. https:\/\/data.stats.gov.cn\/search.htm?s=CPI%20%E5%8C%BB%E7%96%97. Accessed Dec 2, 2024."},{"issue":"1","key":"3384_CR16","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1146\/annurev-publhealth-040617-013517","volume":"39","author":"P Deb","year":"2018","unstructured":"Deb P, Norton EC. Modeling health care expenditures and use. Annu Rev Public Health. 2018;39(1):489\u2013505.","journal-title":"Annu Rev Public Health"},{"issue":"4","key":"3384_CR17","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1093\/biomet\/86.4.948","volume":"86","author":"J Barnard","year":"1999","unstructured":"Barnard J, Rubin D. Miscellanea. Small-sample degrees of freedom with multiple imputation. Biometrika. 1999;86(4):948\u201355.","journal-title":"Biometrika"},{"issue":"1","key":"3384_CR18","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/BF02924688","volume":"31","author":"H Toutenburg","year":"1990","unstructured":"Toutenburg H, Rubin DB. Multiple imputation for nonresponse in surveys. Statist Papers. 1990;31(1):180.","journal-title":"Statist Papers"},{"issue":"11","key":"3384_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2022.100532","volume":"4","author":"CD Mullins","year":"2022","unstructured":"Mullins CD, Pantalone KM, Betts KA, et al. CKD progression and economic burden in individuals with CKD associated with type\u00a02 diabetes. Kidney Med. 2022;4(11):100532.","journal-title":"Kidney Med"},{"issue":"3","key":"3384_CR20","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1053\/j.ajkd.2014.09.023","volume":"65","author":"TJ Hoerger","year":"2015","unstructured":"Hoerger TJ, Simpson SA, Yarnoff BO, et al. The future burden of CKD in the United States: a simulation model for the CDC CKD initiative. Am J Kidney Dis. 2015;65(3):403\u201311.","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"3384_CR21","first-page":"S163","volume":"23","author":"L Golestaneh","year":"2017","unstructured":"Golestaneh L, Alvarez PJ, Reaven NL, et al. All-cause costs increase exponentially with increased chronic kidney disease stage. Am J Manag Care. 2017;23(10):S163\u201372.","journal-title":"Am J Manag Care"},{"issue":"5","key":"3384_CR22","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.ajkd.2003.06.001","volume":"42","author":"TCH Mix","year":"2003","unstructured":"Mix TCH, St. Peter WL, Ebben J, et al. Hospitalization during advancing chronic kidney disease. Am J Kidney Dis. 2003;42(5):972\u201381.","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"3384_CR23","first-page":"1506","volume":"26","author":"K Folkerts","year":"2020","unstructured":"Folkerts K, Petruski-Ivleva N, Kelly A, et al. Annual health care resource utilization and cost among type\u00a02 diabetes patients with newly recognized chronic kidney disease within a large US administrative claims database. J Manag Care Spec Pharm. 2020;26(12):1506\u201316.","journal-title":"J Manag Care Spec Pharm"},{"key":"3384_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/czac101","author":"J Zhu","year":"2022","unstructured":"Zhu J, Wang W, Wang J, Zhu L. Change in coronary heart disease hospitalization after chronic disease management: a programme policy in China. Health Policy Plan. 2022. https:\/\/doi.org\/10.1093\/heapol\/czac101.","journal-title":"Health Policy Plan"},{"key":"3384_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhealeco.2021.102539","volume":"80","author":"H Ding","year":"2021","unstructured":"Ding H, Chen Y, Yu M, et al. The effects of chronic disease management in primary health care: evidence from rural China. J Health Econ. 2021;80:102539.","journal-title":"J Health Econ"},{"issue":"9","key":"3384_CR26","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1681\/ASN.2012040392","volume":"24","author":"AA Honeycutt","year":"2013","unstructured":"Honeycutt AA, Segel JE, Zhuo X, Hoerger TJ, Imai K, Williams D. Medical costs of CKD in the medicare population. J Am Soc Nephrol. 2013;24(9):1478\u201383.","journal-title":"J Am Soc Nephrol"},{"key":"3384_CR27","doi-asserted-by":"publisher","DOI":"10.2337\/db20-29-LB","author":"J Schempf","year":"2020","unstructured":"Schempf J, Freese RL, Caramori L, Harindhanavudhi T. 29-LB: physicians\u2019 chronic kidney disease (CKD) awareness over time in type\u00a02 diabetes (T2D). Diabetes. 2020. https:\/\/doi.org\/10.2337\/db20-29-LB.","journal-title":"Diabetes"},{"issue":"6","key":"3384_CR28","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1053\/j.ajkd.2014.07.030","volume":"64","author":"AS Levey","year":"2014","unstructured":"Levey AS, Inker LA, Matsushita K, et al. GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis. 2014;64(6):821\u201335.","journal-title":"Am J Kidney Dis"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03384-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03384-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03384-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T15:04:28Z","timestamp":1763132668000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03384-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["3384"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03384-4","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"28 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Zaixin Zhao, Yuwei Lin, Peng Shen, Yang Xu, Yexiang Sun, Xun Tang, Huijuan Li, Hongbo Lin and Pei Gao declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The Peking University Health Science Center Ethics Committee approved this study with a waiver of informed consent (IRB00001052-22016).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}